Idéal Investisseur
Français English
CAC 40 : Market closed
7 969,42 pts
-0.01%


Last updated : 30/10/2026 - 17h36
🏠 Home   ➤    Stock news

Virbac brings together nearly 100 specialists in Edinburgh around senior cat health

The veterinary laboratory in Carros organized an international symposium dedicated to the management of senior cats.

The initiative, presented in a press release dated October 1st, 2026, is part of the group's focus on feline geriatrics.


Virbac brings together nearly 100 specialists in Edinburgh around senior cat health

A symposium focused on comorbidities in aging cats

Virbac brought together nearly 100 feline medicine specialists from Europe, the United States and Australia in Edinburgh around the management of elderly cats.

According to the press release, the stated objective is to coordinate prevention, care and nutrition in the face of increasing feline life expectancy and the frequency of comorbidities (kidney disease, hyperthyroidism, joint disorders).

The group highlights early detection and systemic management of age-related pathologies as the focus of this meeting. In his opening remarks, Paul Martingell, CEO of Virbac, stated: "Reaching an advanced age is a milestone, not a surrender of quality of life. Our commitment is to stand alongside veterinarians and pet owners to ensure that every senior cat receives specialized, attentive and cutting-edge care, preserving its vitality and comfort to the end."

Five areas of action presented to practitioners

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

During the day, five international speakers presented their work around five areas of action identified by the group: early diagnosis, endocrinology, renal care and nutrition, mobility and prevention.

Virbac indicates its desire to detect earlier, break down silos in treatments for better management of comorbidities and eliminate stress related to care.

The press release recalls field data cited to support this direction: 90% of cats over 12 years old would suffer from osteoarthritis, one third would be affected by chronic kidney disease, up to 10% of cats over 9 years old would develop hyperthyroidism, and 40% of owners would encounter difficulties administering treatment to their animal.



Sector Pharmacie et biotechnologies › Pharmacie, vaccins et santé animale


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Context

Period
  • Period: 9M 2026
Key reported figures
  • Revenue: 1 168 millions d'euros
  • Quarterly revenue: 1 168 millions d'euros
Guidance from the release
  • Notre solide performance à fin septembre 2026 nous permet de viser le haut de notre fourchette initiale de croissance du chiffre d'affaires
Risks mentioned
  • Effets de change défavorables impactant la croissance réelle (croissance réelle +5,9% vs +7,9% à taux constants)
  • Pression concurrentielle persistante sur les vaccins porcins en Asie de l'Est et pressions tarifaires au segment Animaux d'élevage
  • Exposition au Moyen-Orient et suivi des tendances inflationnistes (énergie) malgré anticipation d'impacts limités
Opportunities identified
  • Croissance soutenue des plateformes Supercharge (+11% environ) couvrant petfood, reproduction, dentaire, mobilité, otologie, endocrinologie et ruminants
  • Intégration fluide de Thyronorm dans la franchise d'endocrinologie avec contribution de +1 point de croissance et +0,5 point d'Ebit ajusté
  • Redémarrage réussi de la production du contrat majeur de façonnage en Amérique du Nord (juillet 2026) après contrainte réglementaire temporaire
Outlook / guidance
  • Expected revenue: 1 575 millions d'euros
  • Management commentary: « Bien que nos perspectives pour l'ensemble de l'année 2026 restent inchangées, notre solide performance à fin septembre (croissance de +7,9%) nous permet de viser la borne haute de notre fourchette de croissance du chiffre d'affaires de 5,5 % à 7,5 % à PCC »

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours